Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis.
Photodynamic inactivation (PDI) of bacterial strains presents an attractive potential alternative to antibiotic therapies. Success is dependent on the effective accumulation in bacterial cells of photochemical substances called photosensitizers, which are usually porphyrins. It is also important to know the distribution of the photosensitizer in bacteria at the microscopic level. The present results examine the accumulation of photosensitizers by Mycobacterium phlei and Mycobacterium smegmatis, which serve as models for the important pathogens Mycobacterium tuberculosis, Mycobacterium leprae and Mycobacterium bovis. The kinetics of porphyrin synthesis after treatment with the precursors ALA and h-ALA were studied. The goal was to describe the biosynthesis and the pharmacokinetics of sensitizers in both bacterial strains using fluorescence microscopy and spectroscopy. We could show that both Mycobacterium strains enrich porphyrins after ALA and h-ALA administration detected by fluorescence peaks at about 620nm. By HPLC analyses the major porphyrin could be identified as coproporphyrin. In the future we will apply the new knowledge in in vitro and in vivo experiments to strains of M. tuberculosis, M. leprae and M. bovis and examine cell destruction by PDI.
Bruce-Micah
R
R
Apocare Pharma GmbH, Bielefeld, Germany. micah@rhrk.uni-kl.de
Hüttenberger
D
D
Freitag
L
L
Cullum
J
J
Foth
H-J
HJ
D000622:Aminolevulinic Acid / Q000031:analogs & derivatives* / Q000378:metabolism*; D008027:Light; D009168:Mycobacterium phlei / Q000378:metabolism* / Q000528:radiation effects; D020102:Mycobacterium smegmatis / Q000378:metabolism* / Q000528:radiation effects; D017319:Photosensitizing Agents / Q000378:metabolism*; D011166:Porphyrins / Q000096:biosynthesis*; D013997:Time Factors
D017319:Photosensitizing Agents; D011166:Porphyrins; D000622:Aminolevulinic Acid; C419924:5-aminolevulinic acid hexyl ester